US urges higher profile for "overlooked" $11bn diagnostics industry
This article was originally published in Clinica
While laboratory tests account for only 5% of US hospital costs and approximately 1.6% of all Medicare costs, their findings influence as much as 60-70% of healthcare decision-making, according to a new study commissioned by AdvaMed.
You may also be interested in...
UK HTA body NICE is looking to the future and rethinking its approach to data and how they inform its guidance.
Slovenia’s Krka has responded to media reports of “irregularities” at its Romanian subsidiary – including allegations of bribing local doctors to prescribe its products – by pledging to form a special investigation team to immediately examine the matter.